Enzyme-linked immunosorbent assay of phenolic glycolipid-I in patients with Hansen’s disease
Main Article Content
Introduction: Hansen’s disease or leprosy is a contagious-infection entity produced by the Hansen bacillus or Mycobacterium leprae. The phenolic glycolipid is a special trisaccharide found in the bacillus cell wall and proved to be specific and immunogenic species during M. leprae.
Objective: To determine the presence of the Hansen bacillus enzyme-linked immunoassay (ELISA) method glycolipid phenolic I in a group of patients in Dermatology Consultation at the Valle del Cauca Health Services; these patients were classified as cures or under watch according to criteria established by the World Health Organization (WHO).
Methodology: From the data base of the Dermatology Consultation at the Valle del Cauca Health Services, we studied 159 patients with Hansen’s disease who were tested with the enzyme-linked immunoassay (ELISA) with the phenolic glycolipid I to cross reference information and observe if they were or were not positive to this test. A positive ELISA indicates the bacillus is still present in the patient.
Results: As an important fact, we found that of 78 patients cured, when bearing in mind the monitoring period, 9 were positive for the ELISA. When this period was discarded, 81 sick individuals were classified as cured according to WHO criteria but the same 9 continued positive for ELISA.
Conclusion: It may be concluded that in spite of meeting WHO criteria, these patients still show presence of the bacillus and the monitoring period is not required as a criterion to discharge a patient. We recommend adding to WHO criteria a negative ELISA, to obtain additional information that helps to certify that a patient is or is not cured.
Objective: To determine the presence of the Hansen bacillus enzyme-linked immunoassay (ELISA) method glycolipid phenolic I in a group of patients in Dermatology Consultation at the Valle del Cauca Health Services; these patients were classified as cures or under watch according to criteria established by the World Health Organization (WHO).
Methodology: From the data base of the Dermatology Consultation at the Valle del Cauca Health Services, we studied 159 patients with Hansen’s disease who were tested with the enzyme-linked immunoassay (ELISA) with the phenolic glycolipid I to cross reference information and observe if they were or were not positive to this test. A positive ELISA indicates the bacillus is still present in the patient.
Results: As an important fact, we found that of 78 patients cured, when bearing in mind the monitoring period, 9 were positive for the ELISA. When this period was discarded, 81 sick individuals were classified as cured according to WHO criteria but the same 9 continued positive for ELISA.
Conclusion: It may be concluded that in spite of meeting WHO criteria, these patients still show presence of the bacillus and the monitoring period is not required as a criterion to discharge a patient. We recommend adding to WHO criteria a negative ELISA, to obtain additional information that helps to certify that a patient is or is not cured.
Moreno, L. H., & Alzate, A. (2010). Enzyme-linked immunosorbent assay of phenolic glycolipid-I in patients with Hansen’s disease. Colombia Medica, 41(2), 155–160. https://doi.org/10.25100/cm.v41i.2.697
Downloads
Download data is not yet available.
- Alberto Alzate, Rodolfo Herrera, Lucia Maracelly Pineda, Preeclampsia prevention: a case-control study nested in a cohort , Colombia Medica: Vol. 46 No. 4 (2015)
- Adriana Rengifo, Eduardo de Lima, Gustavo Mariño, Alfredo Rengifo, José Humberto Arango, Alberto Alzate, Fernando Tuffi García, Martha Susana Forero, Matilde de Bernal, Gloria Gamboa, Estandarización de valores de vaciamiento gástrico en sujetos normales por estudio gammagráfico en Cali. , Colombia Medica: Vol. 29 No. 1 (1998)
- Alberto Alzate, Adolfo Vélez G, Historia clínica simplificada I. (Aplicación de un cuestionario de salud) , Colombia Medica: Vol. 14 No. 1 (1983)
- Luz Ángela González de Polanía, Alberto Alzate, Nancy Saravia, Evaluación de la inmunoperoxidasa en el diagnóstico diferencial entre la esporotricosis y la leishmaniasis experimental. , Colombia Medica: Vol. 22 No. 4 (1991)
- Gustavo Mariño, Eduardo de Lima, Fernado Tuffi García, Carlos Cuello, Harold Cuello, Alberto Alzate, Concordancia endoscópico-histológica de la gastritis crónica en Cali , Colombia Medica: Vol. 29 No. 1 (1998)
- Jorge Humberto Rojas Palacios, Alberto Alzate, Héctor Jairo Martínez Romero, Alberto Ignacio Concha-Eastman, Authors Response: Reflections on Afro-descendant origin and the outcome of dengue fever cases in Colombia. , Colombia Medica: Vol. 48 No. 2 (2017)
- Rodolfo Herrera, Alberto Alzate, Lucia M Pineda, Authors Response: Preeclampsia prevention: a case-control study nested in a cohort , Colombia Medica: Vol. 47 No. 1 (2016)
- Luis Fernando Cruz, Luz Nelly Girón, Rodrigo Velásquez, Lina María García, Alberto Alzate, Coberturas de vacunación en el Valle del Cauca, 2002 , Colombia Medica: Vol. 34 No. 1 (2003)
- María del Pilar Crespo Ortiz, Raúl Corral Prado, Alberto Alzate, Micobacterias no tuberculosas en personas VIH positivas y en personas sin factores de riesgo a la infección. , Colombia Medica: Vol. 28 No. 3 (1997)
- Rafael Caicedo, Gloria Argüelles, Alberto Alzate, Exposición a dosis bajas de radiación ionizante en el Hospital Universitario del Valle, Cali, 1980-1992. , Colombia Medica: Vol. 27 No. 3,4 (1996)
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use